We are committed to developing innovative solutions for a broad range of serious and chronic health conditions, with the goal of advancing medical care and addressing unmet patient needs.
Our work in medicines and diagnostics is driven by a commitment to improving patient outcomes, supporting better quality of life, and promoting sustainable access to healthcare for individuals and communities worldwide.
Addressing unmet medical needs is central to our mission. Through innovative solutions and dedicated research, we strive to improve patient care and contribute to better health outcomes.
Psoriasis is a common, chronic inflammatory condition, caused by dysfunction of the immune system, which results in skin cells reproducing at a faster rate than normal.
Hidradenitis suppurativa (HS), is a chronic, recurring, painful and debilitating inflammatory skin disease.
Myasthenia gravis is a rare, chronic, autoimmune, neuromuscular condition where the body’s immune system mistakenly targets the connection between the nerves and the muscles.
For more than 30 years, we have focused on discovering solutions that have helped transform the epilepsy treatment landscape and improve the lives of millions of people.